文献速递膀胱癌与上尿路尿路上皮癌

根治性膀胱切除术的时段特异性年均医院手术量与被实施手术患者的结局及围手术期医疗质量相关:一项全国性人群研究

Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study.
PubMed 文献 · BJU Int · 2019-04-22

研究利用瑞典膀胱癌数据库(BladderBaSe)纳入1997至2014年间因原发性浸润性膀胱癌(T1-T3期)行根治性膀胱切除术的全部3172例患者,分析时段特异性年均医院手术量与总生存、癌特异性生存及围手术期质量指标的关系。结果显示最高三分位(年均≥25例)与总生存改善相关(HR 0.87,95%CI 0.75-1.0),年均每增加10例总生存改善(HR 0.95,95%CI 0.90-0.99),且较高手术量与扩大淋巴结清扫、可控性尿流改道和新辅助化疗使用增加相关,但治疗延迟超过3个月也更常见。

要点

  • 年均根治性膀胱切除术≥25例的医院总生存改善(HR 0.87,95%CI 0.75-1.0)。
  • 年均每增加10例,总生存改善(HR 0.95,95%CI 0.90-0.99)。
  • 较高手术量与扩大淋巴结清扫、可控性尿流改道及新辅助化疗增加相关,但治疗延迟超过3个月也更常见。

核心结论

  • 本研究支持膀胱癌根治性膀胱切除术的集中化,同时强调需监测与转诊相关的治疗延迟。

研究设计与样本

  • 利用瑞典膀胱癌数据库(BladderBaSe)纳入1997至2014年间因原发性浸润性膀胱癌(T1-T3期)行根治性膀胱切除术的全部3172例患者。
  • 暴露为手术前3年内的时段特异性年均医院手术量,采用单因素和多因素混合模型分析,校正肿瘤及淋巴结分期、年龄、性别、合并症、教育水平和新辅助化疗。

主要发现

  • 最高三分位(年均≥25例)与总生存改善相关(HR 0.87,95%CI 0.75-1.0),癌特异性生存的相应HR为0.87(95%CI 0.73-1.04)。
  • 时段特异性年均医院手术量作为连续变量时,年均每增加10例总生存改善(HR 0.95,95%CI 0.90-0.99)。
  • 较高时段特异性年均医院手术量与扩大淋巴结清扫、可控性尿流改道和新辅助化疗使用增加相关。
  • 较高时段特异性年均医院手术量与诊断后治疗延迟超过3个月更常见相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the association between hospital volume and overall survival (OS), cancer-specific survival (CSS), and quality of care of patients with bladder cancer who undergo radical cystectomy (RC), defined as the use of extended lymphadenectomy (eLND), continent reconstruction, neoadjuvant chemotherapy (NAC), and treatment delay of <3 months. PATIENTS AND METHODS: We used the Bladder Cancer Data Base Sweden (BladderBaSe) to study survival and indicators of perioperative quality of care in all 3172 patients who underwent RC for primary invasive bladder cancer stage T1-T3 in Sweden between 1997 and 2014. The period-specific mean annual hospital volume (PSMAV) during the 3 years preceding surgery was applied as an exposure and analysed using univariate and multivariate mixed models, adjusting for tumour and nodal stage, age, gender, comorbidity, educational level, and NAC. PSMAV was either categorised in tertiles, dichotomised (at ≥25 RCs annually), or used as a continuous variable for every increase of 10 RCs annually. RESULTS: PSMAV in the highest tertile (≥25 RCs annually) was associated with improved OS (hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.75-1.0), whereas the corresponding HR for CSS was 0.87 (95% CI 0.73-1.04). With PSMAV as a continuous variable, OS was improved for every increase of 10 RCs annually (HR 0.95, 95% CI 0.90-0.99). Moreover, higher PSMAV was associated with increased use of eLND, continent reconstruction and NAC, but also more frequently with a treatment delay of >3 months after diagnosis. CONCLUSIONS: The current study supports centralisation of RC for bladder cancer, but also underpins the need for monitoring treatment delays associated with referral.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Liedberg F, Hagberg O, Aljabery F, et al. Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study. BJU Int. 2019. PMID: 30950568. doi:10.1111/bju.14767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。